line
line
line
line
line
line line
line

2018 BioMAN Summit

Agenda for Day 2: December 12, 2018

line
7:30 AM – 8:15 AM Breakfast
line
Introduction
8:15 AM – 8:20 AM Stacy L. Springs, MIT CBI
view bio
line
Opening Remarks
line
8:20 AM – 8:35 AM Funding Approaches for Incentivizing Innovation and Biomanufacturing
Travis A. McCready
President and Chief Executive Officer, Massachusetts Life Sciences Center
view bio
line
Keynote Presentation
line
8:35 AM – 9:20 AM Human Gene Therapy – The Road to Today and Beyond
Guangping Gao
Co-Director, Li Weibo Institute for Rare Diseases Research, Director, Horae Gene Therapy Center and Viral Vector Core, Professor of Microbiology and Physiological Systems, Penelope Booth Rockwell Professor in Biomedical Research, University of Massachusetts Medical School
view bio | view abstract
line
Framing the Day
line
9:20 AM - 9:35 AM Jacqueline Wolfrum
Associate Director, Biomanufacturing Program, MIT CBI
view bio
line
Session 2: New Platforms
line
  Morning Chair: Jacqueline Wolfrum, MIT CBI
view bio
line
9:35 AM to 10:00 AM Cell Therapy Manufacturing Platforms: How to Meet Today’s and Tomorrow’s Challenges
Gregory Russotti
Vice President, Cell Therapy Technical Development, Celgene
view bio | view abstract
line
10:00 AM – 10:25 AM Refreshment Break
line
10:25 AM – 10:45 AM Expansion of Human Induced Pluripotent Stem Cells in Stirred Suspension Culture
Aletta Schnitzler
Head of Collaborations, Cell Therapy Bioprocessing, MilliporeSigma
view bio | view abstract
line
10:45 AM – 11:10 AM Beyond Automated iPSC Reprogramming: Applications for a Fully-Automated System
Elizabeth Schwarzbach
Chief Business Officer, New York Stem Cell Foundation Research Institute
view bio | view abstract
line
11:10 AM – 11:30 AM High-Titer Lentivirus Production in Suspension Cell Culture Systems Using Transient Transfection
Onur Kas
Senior Scientist, Virus and Gene Therapy Bioprocessing, MilliporeSigma
view bio | view abstract
line
11:30 AM – 11:55 AM Technologies for High-Quality Manufacturing of Autologous Cell Therapies
Rajeev Ram
Professor of Electrical Engineering and Computer Science,
MIT
view bio | view abstract

Harry Lee
Co-Founder and President,
Pharyx
view bio | view abstract
line
Academic Poster Awards
11:55 AM – 12:15 PM Presented by: Stephanie Flores, Executive Director, CASSS, John Frenz, Distinguished Fellow, CASSS, and Stacy L. Springs, Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI
line
12:15 PM – 1:15 PM Lunch
line
Session 3: New Challenges
line
  Afternoon Chair: James C. Leung, MIT CBI
view bio
line
1:15 PM – 1:40 PM Laser Force Cytology for Label-Free Single Cell Analysis and its Applicability in Cell Therapy Biomanufacturing
Colin Hebert
Vice President, Biotechnology, LumaCyte
view bio | view abstract
line
1:40 PM – 2:05 PM Digital Cell Biology At Light Speed
Warren Davis
Sales Account Manager, Berkeley Lights
view bio | view abstract
line
2:05 PM – 2:25 PM Analytical Opportunities and Challenges in Developing CAR T-cell Therapies
Trent Munro
Executive Director of Process Development, Attribute Sciences, Amgen
view bio | view abstract
line
2:25 PM – 2:50 PM Establish Efficient Approaches to Quantify rAAV Vectors and Build a Robust Path to the Clinic
Vivian Choi
Director, Head of Gene Therapy Research US, Discovery Therapeutics, US Drug Discovery, Shire
view bio | view abstract
line
2:50 PM – 3:15 PM Real-Time Microbial Detection for Biomanufacturing
Nicholas Brancazio
Microbiology Associate,
Fluid-Screen
view bio | view abstract
line
3:15 PM – 3:40 PM Refreshment Break
line
3:40 PM – 4:05 PM Critical Attributes of Stem Cells for Therapeutic Efficacy: Engineering and Understanding Manufacturing Implications
Krystyn Van Vliet
Associate Provost; Michael and Sonja Koerner Professor of Materials Science and Engineering and Professor of Biological Engineering, MIT
view bio | view abstract
line
4:05 PM – 4:30 PM Challenges and Opportunities in AAV Manufacturing for Gene Therapy
Nicole K. Paulk
Assistant Professor, Department of Biochemistry & Biophysics, University of California, San Francisco; Visiting Scientist, Genome Engineering, Chan Zuckerberg Biohub
view bio | view abstract
line
4:30 PM – 4:55 PM Lessons from the CAACB for Cell and Gene Therapy Products
Paul W. Barone
Director, Biomanufacturing Program and the Consortium on Adventitious Agent Contamination in Biomanufacturing, MIT CBI
view bio | view abstract
line
4:55 PM – 5:20 PM Coverage and Reimbursement for High-Cost Curative Therapies
Casey Quinn
Research Advisor, NEWDIGS FoCUS Project, MIT CBI
view bio | view abstract
line
Closing Remarks
line
5:20 PM – 5:30 PM Stacy L. Springs
Executive Director, Biomanufacturing Initiatives; Senior Director of Programs, MIT CBI
view bio
line
bottom line
MIT CBI BioMAN